Leocor Corflo Model 7.5PT PTCA Catheter
by Leocor, Inc.
PMA P890001
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP890001 | Date30 Mar 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Leocor Corflo(Tm) Model 7.5PT Ptca Catheter
- Trade Name
- Leocor,inc. Models 1
- Generic Name
- Catheters, transluminal coronary angioplasty, percutaneous
- PMA Number
- FDA Product Code
- LOX
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.5100
- Advisory Committee
- Cardiovascular
- FDA Decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Leocor Corflo Model 7.5PT PTCA Catheter is a Catheter, Transluminal Coronary Angioplasty, Percutaneous, designed for use in percutaneous transluminal coronary angioplasty (PTCA) procedures. It is intended to dilate narrowed or obstructed coronary arteries by inflating a balloon at the catheter tip, restoring blood flow to the affected region.
This catheter is supplied as a single-use device and is regulated under the FDA_PMA authorization, with approval granted under PMA number P890001. It is classified as a Class II medical device under regulation number 870.5100 and is intended for use in controlled clinical settings, such as cardiac catheterization labs. The device is not labeled for MRI use and must be stored in accordance with manufacturer instructions to maintain sterility and functionality.
Other devices from Leocor, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary clinical purpose of the Leocor Corflo Model 7.5PT PTCA Catheter, and where would it typically be used?
The Leocor Corflo Model 7.5PT PTCA Catheter is specifically designed for percutaneous transluminal coronary angioplasty (PTCA), a procedure to widen narrowed or blocked coronary arteries. It achieves this by inflating a balloon at the catheter tip, restoring blood flow to the affected area. This device is intended for use in controlled clinical settings, such as cardiac catheterization labs, where interventional cardiologists perform coronary artery interventions.
Is the Leocor Corflo Model 7.5PT PTCA Catheter intended for reuse, or is it single-use only?
The device is explicitly labeled as single-use only, meaning it is not designed for reuse after a single procedure. This ensures patient safety and sterility, as reuse could compromise the device’s integrity and introduce infection risks.
How should the Leocor Corflo Model 7.5PT PTCA Catheter be stored to maintain its sterility and functionality?
The manufacturer instructs that the device must be stored in accordance with their specific guidelines to preserve sterility and functionality. While the exact storage conditions (e.g., temperature, packaging) aren’t detailed here, standard practice for single-use catheters typically involves keeping them in their original, sealed packaging in a clean, dry environment away from direct sunlight or extreme temperatures until use.
What regulatory pathway was followed for the approval of this device, and what classification does it hold?
The Leocor Corflo Model 7.5PT PTCA Catheter was approved through the FDA’s Premarket Approval (PMA) process, with approval granted under PMA number P890001. It is classified as a Class II medical device under regulation number 870.5100, indicating it requires a higher level of scrutiny due to its role in life-sustaining or life-supporting procedures.